Regorafenib
Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor (IC50s: 1.5/2.5/4.2/7/13/22 nM for RET/C-RAF/VEGFR2/c-Kit/VEGFR1/PDGFRβ).
| Catalog Number | T1792 |
| Alternative Name(s) | BAY 73-4506 , Fluoro-Sorafenib |
| Research Area | Tyrosine Kinase/Adaptors|||Apoptosis|||Autophagy|||Angiogenesis|||MAPK |
| Molecular Formula | C21H15ClF4N4O3 |
| CAS# | 755037-03-7 |
| Purity | 99.87% |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Regorafenib |
| Additional Information | https://www.targetmol.com/datasheet/T1792 |
